Erakusten 1 - 13 emaitzak -- 13 bilaketa honetara 'Jing Wang (14959256)', Bilaketaren denbora: 0,01s Findu emaitzak
  1. 1
    Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

    Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers nork Juliana Navarro-Yepes (17079059)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC nork Sonia A. Patel (15055688)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC nork Sonia A. Patel (15055688)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC nork Sonia A. Patel (15055688)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC nork Sonia A. Patel (15055688)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC nork Sonia A. Patel (15055688)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... nork Abdullah A. Osman (15056323)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... nork Abdullah A. Osman (15056323)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... nork Abdullah A. Osman (15056323)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... nork Abdullah A. Osman (15056323)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer

    Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer nork Kavya Ramkumar (16474203)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... nork Abdullah A. Osman (15056323)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous... nork Abdullah A. Osman (15056323)

    Argitaratua 2025
    Beste egile batzuk:
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: